BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31904145)

  • 21. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold.
    Berardozzi S; Bernardi F; Infante P; Ingallina C; Toscano S; De Paolis E; Alfonsi R; Caimano M; Botta B; Mori M; Di Marcotullio L; Ghirga F
    Eur J Med Chem; 2018 Aug; 156():554-562. PubMed ID: 30025349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli.
    Zhan X; Wang J; Liu Y; Peng Y; Tan W
    Mol Cancer; 2014 Jan; 13():4. PubMed ID: 24393163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo.
    Guo J; Gao J; Li Z; Gong Y; Man X; Jin J; Wu H
    Cancer Lett; 2013 Oct; 339(2):185-94. PubMed ID: 23791879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoothened transduces Hedgehog signal by forming a complex with Evc/Evc2.
    Yang C; Chen W; Chen Y; Jiang J
    Cell Res; 2012 Nov; 22(11):1593-604. PubMed ID: 22986504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P; Zhang X; Liu H; Chen L
    DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.
    Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
    Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-1α/ATG5 axis.
    Zhou Y; Liu T; Wu Q; Wang H; Sun Y
    Mol Carcinog; 2023 Oct; 62(10):1474-1486. PubMed ID: 37283234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Smoothened in Cancer.
    Jeng KS; Sheen IS; Leu CM; Tseng PH; Chang CF
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Hedgehog Signaling in Fibroblasts, Pancreatic, and Lung Tumor Cells by Oxy186, an Oxysterol Analogue with Drug-Like Properties.
    Wang F; Stappenbeck F; Parhami F
    Cells; 2019 May; 8(5):. PubMed ID: 31137846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Nedd4 as a novel regulator in Hedgehog signaling.
    Luo QF; Chen W; Zhang ST
    Chin Med J (Engl); 2012 Nov; 125(21):3851-5. PubMed ID: 23106887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of hedgehog signaling and its association with cisplatin resistance in ovarian epithelial tumors.
    Song X; Yan L; Lu C; Zhang C; Zhu F; Yang J; Jing H; Zhang Y; Qiao J; Guo H
    Oncol Lett; 2018 Apr; 15(4):5569-5576. PubMed ID: 29552194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma.
    Mori Y; Okumura T; Tsunoda S; Sakai Y; Shimada Y
    Oncology; 2006; 70(5):378-89. PubMed ID: 17179732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma.
    Pietrobono S; Gaudio E; Gagliardi S; Zitani M; Carrassa L; Migliorini F; Petricci E; Manetti F; Makukhin N; Bond AG; Paradise BD; Ciulli A; Fernandez-Zapico ME; Bertoni F; Stecca B
    Oncogene; 2021 Jun; 40(22):3799-3814. PubMed ID: 33958721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.
    Huang L; Walter V; Hayes DN; Onaitis M
    Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas.
    Atwood SX; Li M; Lee A; Tang JY; Oro AE
    Nature; 2013 Feb; 494(7438):484-8. PubMed ID: 23446420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABT-737 suppresses aberrant Hedgehog pathway and overcomes resistance to smoothened antagonists by blocking Gli.
    Huang W; Liu H; Tan W; Wang J
    Med Oncol; 2022 Sep; 39(12):188. PubMed ID: 36071246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.
    Rahman MM; Hazan A; Selway JL; Herath DS; Harwood CA; Pirzado MS; Atkar R; Kelsell DP; Linton KJ; Philpott MP; Neill GW
    Cancer Res; 2018 May; 78(10):2577-2588. PubMed ID: 29463581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
    Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
    Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.